Biological characterization of Campylobacter fetus lipopolysaccharides

FEMS Immunology and Medical Microbiology

Volumn 15, Issue 1, 1996, Pages 43-50

  Moran, Anthony P ^a   O'Malley, David T ^a   Vuopio Varkila, Jaana ^b   Varkila, Kari ^b   Pyhälä, Liisa ^b   Saxén, Harri ^c   Helander, Ilkka M ^b  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Biological activity; Campylobacter fetus; Endotoxin; Lipid A; Lipopolysaccharide

Indexed keywords

ENDOTOXIN; LIPID; LIPID A; LIPOPOLYSACCHARIDE; MITOGENIC AGENT; PYROGEN; SUGAR;

ANIMAL CELL; ARTICLE; CAMPYLOBACTER FETUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTYPE;

EID: 0030220740     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/0928-8244(96)00043-0     Document Type: Article

References (39)

1. [1] Garcia, M.M., Eaglesome, M.D. and Rigby, C. (1983) Campylobacters important in veterinary medicine. Vet. Bull. 53, 793-818.
2. [2] Véron, M. and Chatelain, R. (1973) Taxonomic study on the Campylobacter Sebald and Véron and designation of the neotype strain for the type species, Campylobacter fetus (Smith and Taylor) Sebald and Véron. Int. J. Syst. Bacteriol. 23, 122-134.
3. [3] Guerrant, R.L., Lahita, R.G., Winn, W.C. and Roberts, R.B. (1978) Campylobacteriosis in man: pathogenic mechanisms and review of 91 blood stream infections. Am. J. Med. 65, 584-592.
4. [4] Penner, J.L. (1988) The genus Campylobacter: a decade of progress. Clin. Microbiol. Rev. 1, 157-172.
5. [5] Neuzil, K.M., Wang, E., Haas, D.W. and Blaser, M.J. (1994) Persistence of Campylobacter fetus bacteremia associated with absence of opsonizing antibodies. J. Clin, Micro. 23, 1718-1720.
6. [6] Klein, B.S., Vergeron, J.M., Blaser, M.J., Edmonds, P., Brenner, D., Janssen, D. and Davis, J.P. (1986) An outbreak of Campylobacter jejuni and thermotolerant Campylobacter fetus subsp. fetus associated with raw milk. JAMA 255, 361-364.
7. [7] Dworkin, J., Tummuru, M.K.R. and Blaser, M.J. (1995) Segmental conservation of sapA sequences in type B Campylobacter fetus cells. J. Biol. Chem. 270, 15093-15101.
8. [8] Blaser, M.J. and Pei, Z. (1993) Pathogenesis of Campylobacter fetus infections: critical role of high-molecular-weight S-layer proteins in virulence. J. Infect. Dis. 167, 372-377.
9. [9] Rietschel, E.T., Brade, L., Holst, O., Kulshin, V.A., Lindner, B., Moran, A.P., Schade, U.F., Zähringer, U. and Brade, H. (1990) Cellular and Molecular aspects of Endotoxin Reactions. In: Endotoxin Research Series (Nowotny, A., Spitzer, J.J. and Zierler, E.J., Eds.), pp. 15-32. Elsevier Science Publishers B.V., Amsterdam.
10. [10] Moran, A.P. (1995) Structure-bioactivity relationships of bacterial endotoxins. J. Toxicol. Toxin Rev. 14, 47-83.
11. [11] Perez-Perez, G.I., Blaser, M.J. and Bryner, J.H. (1986) Lipopolysaccharide structures of Campylobacter fetus are related to heat-stable serogroups. Infect. Immun. 51, 209-212.
12. [12] Perez-Perez, G.I. and Blaser, M.J. (1985) Lipopolysaccharide characterization of pathogenic Campylobacters. Infect. Immun. 47, 353-359.
13. [13] Perez-Perez, G.I., Hopkins, J.A. and Blaser, M.J. (1985) Antigenic heterogeneity of lipopolysaccharide from Campylobacter jejuni and Campylobacter fetus. Infect. Immun. 48, 528-533.
14. [14] Kosunen, T.U. (1986) Serotyping of Campylobacter fetus subsp. fetus and C. fetus subsp. venerealis by passive hemagglutination technique based on soluble autoclaved antigens. Acta Pathol. Microbiol. Immunol. Scand. Sect. B 94, 245-249.
15. [15] Moran, A.P. (1995) Biological and serological characterization of Campylobacter jejuni lipopolysaccharides with deviating core and lipid A structures. FEMS Immunol. Med. Microbiol. 11, 121-130.
16. [16] Muotiala, A., Helander, I.M., Pyhälä, L., Kosunen, T.U. and Moran, A.P. (1990) Low biological activity of Helicobacter pylori lipopolysaccharide. Infect. Immun. 60, 1714-1716.
17. [17] Sukupolvi, S., Vaara, M., Helander, I.M., Viljanen, P. and Mäkelä, P.H. (1984) New Salmonella typhimurium mutants with altered outer membrane permeability. J. Bacteriol. 159, 704-712.
18. [18] Moran, A.P., O'Malley, D.T., Kosunen, T.U. and Helander, I.M. (1994) Biochemical characterization of Campylobacter fetus lipopolysaccharides. Infect. Immun. 62, 3922-3929.
19. [19] Westphal, O., Lüderitz, O. and Bister, F. (1952) Über die Extraktion von Bakterien mit Phenol/Wasser. Z. Naturforsch. 7b, 148-155.
20. [20] Dubois, M., Giles, K.A., Hamilton, J.K., Rebers, P.A. and Smith, F. (1956) Colorimetric method for determination of sugars and related substances. Anal. Chem. 28, 350-356,
21. [21] Galanos, C. and Lüderitz, O. (1975) Electrodialysis of lipopolysaccharides and their conversion to uniform salt forms. Eur. J. Biochem. 54, 603-610.
22. [22] Saxén, H., Vuopio-Varkila, J., Luk, J., Lindberg, A., Lang, A., Di Padova, F., Cryz, S.J., Mertsola, J., McCracken, G.H. and Hansen, E.J. (1993) Detection of enterobacterial lipopolysaccharide and experimental endotoxemia by means of an immunolimulus assay using both serotype-specific and cross-reactive antibodies. J. Infect. Dis. 168, 393-399.
23. [23] Galanos, C., Freudenberg, M.A. and Reutter, W. (1979) Galactosamine induced sensitization to the lethal effects of endotoxin. Proc. Natl. Acad. Sci. USA 75, 5939-5943.
24. [24] Reed, L.J. and Muench, H. (1938) A simple method for estimating fifty percent endpoints. Am. J. Hyg. 27, 493-497.
25. [25] European Pharmacopoeia (1986) 2nd ed. Part 1, V.2.1.4. Maisonneuve S.A., Sainte-Ruffine, France.
26. [26] Moran, A.P., Zähringer, U., Seydel, U., Scholz, D., Stütz, P. and Rietschel, E.T. (1991) Structural analysis of the lipid A component of Campylobacter jejuni CCUG 10936 (serotype 0:2) lipopolysaccharide. Description of a lipid A containing a hybrid backbone of a 2-amino-2-deoxy-D-glucose and 2,3-diamino-2,3-dideoxy-D-glucose. Eur. J. Biochem. 198, 459-469.
27. [27] Moran, A.P., Helander. I.M. and Kosunen, T.U. (1992) Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides. J. Bacteriol. 174, 1370-1377.
28. [28] Strominger, J.L., Park, J.T. and Thompson, R.E. (1959) Composition of the cell wall of Staphylococcus aureus: its relation to the action of penicillin. J. Biol. Chem. 234, 3263-3268.
29. [29] Lowry, O.H., Robert, R., Leiner, K.Y., Wu, M.L. and Farr, A.L. (1954) The quantitative histochemistry of brain. I. Chemical methods. J. Biol. Chem. 207, 1-17.
30. [30] Takada, H. and Kotani, S. (1992) Structure-function relationships of lipid A. In: Bacterial Endotoxic Lipopolysaccharides, Molecular Biochemistry and Cellular Biology (Morrison, D.C., Ryan, J.L., Eds.), pp. 107-134. CRC Press, Boca Raton.
31. [31] Kanegasaki, S., Tanamoto, K.-I., Yasuda, T., Homma, J.Y., Matsuura, M., Nakatsuka, M., Kumazawa, Y., Yamamoto, A., Shiba, T., Kusumoto, S., Imoto, M., Yoshimura, H. and Shimamoto, T. (1986) Structure-activity relationship of lipid A: comparison of biological activities of natural and synthetic lipid A's with different fatty acid compositions. J. Biochem. (Tokyo) 99, 1203-1210.
32. [32] Rietschel, E.T., Kirikae, T., Schade, F.U., Mamat, U., Schmidt, G., Loppnow, H., Ulmer, A.J., Zähringer, U., Seydel, U., Di Padova, F., Schreier, M. and Brade, H. (1994) Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 8, 217-225.
33. [33] Kumazawa, Y., Nakatsuka, M., Takimoto, H., Furuya, T., Nagumo, T., Yamamoto, A., Homma, J.Y., Inada, K., Yoshida, M., Kiso, M. and Hasegawa, A. (1988) Importance of fatty acid substituents of chemically synthesized lipid A-subunit analogs in the expression of immunopharmacological activity. Infect. Immun. 56, 149-155.
34. [34] Brandenburg, K. and Seydel, U. (1990) Investigation into the fluidity of lipopolysaccharide and free lipid A membrane systems by Fourier-transform infrared spectroscopy and differential scanning calorimetry. Eur. J. Biochem. 191, 229-236.
35. [35] Brandenberg, K., Mayer, H., Koch, M.H.J., Weckesser, J., Rietschel, E.T. and Seydel, U. (1993) Influence of the supramolecular structure of free lipid A on its biological activity. Eur. J. Biochem. 218, 555-563.
36. [36] Seydel, U., Labischinski, H., Kastowsky, M. and Brandenburg, K. (1993) Phase behaviour, supramolecular structure, and molecular conformation of lipopolysaccharide. Immunobiology 187, 191-211.
37. [37] Seydel, U. and Brandenburg, K. (1992) Supramolecular structure of lipopolysaccharides and lipid A. In: Bacterial Endotoxic Lipopolysaccharides, Molecular Biochemistry and Cellular Biology (Morrison, D.C. and Ryan, J.L., Eds.) pp. 225-250, CRC Press, Boca Raton.
38. [38] Loppnow, H., Brade, H., Dürrbaum, I., Dinarello, C.A., Kusumoto, S., Rietschel, E.T. and Flad, H.D. (1989) Interleukin 1 induction-capacity of defined lipopolysaccharide partial structures. J. Immunol. 142, 3229-3238.
39. [39] Feist, W., Musehold, J., Brade, H., Ulmer, A.J., Kasumoto, S. and Flad, H.-D. (1989) Induction of tumour necrosis factor-alpha release by lipopolysaccharide and defined lipopolysaccharide partial structures. Immunobiology 179, 293-307.